M.D. Anderson Cancer Center
To help people with high-risk cancer variants to follow cancer surveillance guidelines and lower their risk of developing the disease.
Primary Objective 1\. The primary objective of this study is to assess feasibility of the intervention by achieving benchmarks, including: 1. Design and development of the iPhone/Android application; 2. Collation of a network of providers with expertise in BRCA1/2 and Lynch Syndrome by state/region for enrolled participants; 3. Enrollment of participants within a 6-month period; 4. Engagement of participants via standardized digital user analytics (number of downloads, active users, monthly active users, conversion rate); and 5. Completion of baseline and interval surveys
Eligibility Criteria Part 1 inclusion criteria: 1. Female participants. 2. 18 years of age or older; 3. With known deleterious/pathogenic mutation or likely pathogenic/deleterious variant in HBOC genes (BRCA1/2) or Lynch associated genes (MLH1, MSH2, MSH6, PMS2, EPCAM); 4. Speaks and reads English or Spanish; and 5. Has access to a smartphone with operating system compatible with iOS/Android applications. Part 2 inclusion criteria: 1. Female participants. 2. With known deleterious/pathogenic mutation or likely pathogenic/deleterious variant in HBOC genes (BRCA1/2) or Lynch associated genes…
Standard of Care, no efforts will be made toward any of the study objectives
Up to three interviews may be conducted per participant, and they may take place remotely via a secure videoconferencing service to limit disruptions to the participants schedule as well as any financial burden associated with travel.
Arctuva estimate
Verify or correct the compensation shown for this listing.